Showing results (151-160 of 495) with videos related to
Sort By:
Pageof 50
Inorganic Chemistry|February 28, 2001
Cu(II)- and Hg(II)-induced modulation of the fluorescence behavior of a redox-active sensor moleculeG Hennrich, W Walther, U Resch-Genger, et al.Biochemical and Biophysical Research Communications|November 30, 2017
CD40L and TNF both activate the classical NF-κB pathway, which is not required for the CD40L induced alternative pathway in endothelial cellsJ Seigner, J Basilio, U Resch, et al.Prostaglandins, Leukotrienes, and Medicine|November 1, 1986
Influence of type IIa, IIb and IV-hyperlipoproteinemia on platelet prostaglandin sensitivity, plasma thromboxane B2 and platelet half-lifeE Strobl-Jäger, K Widhalm, H SinzingerActa Histochemica|January 1, 1985
[A semiquantitative method of determining alkaline phosphatase activity in human arterial wall]E Strobl-Jäger, W Firbas, H SinzingerProstaglandins, Leukotrienes, and Medicine|August 1, 1984
Plasma factor and platelet sensitivity to prostacyclin in patients with peripheral vascular disease before and after treatment with a combination of a cyclooxygenase and a phosphodiesterase inhibitorE Strobl-Jäger, J Kaliman, H SinzingerProstaglandins, Leukotrienes, and Medicine|March 1, 1984
Prostacyclin-synthesis-stimulating plasma factor in patients with different stages of hepatic comaP Polterauer, H Sinzinger, B A PeskarJournal of Cardiovascular Pharmacology|October 13, 2005
Troglitazone inhibits long-term glycation and oxidation of low-density lipoproteinGrazyna Sobal, E J Menzel, H SinzingerProstaglandins, Leukotrienes, and Medicine|September 1, 1986
Prostacyclin synthesis stimulating plasma factor in coronary heart diseaseH Sinzinger, J Kaliman, B A PeskarExperimental Pathology|January 1, 1988
High-performance-liquid-chromatographic analysis of radiolabelled prostaglandins and fatty acids with the radial compression columnC Wirthumer-Hoche, I Virgolini, H SinzingerProstaglandins, Leukotrienes, and Medicine|February 1, 1986
Degradation of prostacyclin in the plasma of patients with terminal liver insufficiencyP Polterauer, H Sinzinger, B A PeskarPageof 50